Shinzo Hiroi

Treatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study

Rimei Nishimura, Haruka Kato, Koichi Kisanuki et al. · BMJ Open · 2019 · 97 citations · Full text

GPR40‐induced insulin secretion by the novel agonist TAK‐875: first clinical findings in patients with type 2 diabetes

Tsuyoshi Araki, Masashi Hirayama, Shinzo Hiroi et al. · Diabetes Obesity and Metabolism · 2011 · 96 citations

Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled trial with an open‐label long‐term extension study

Kohei Kaku, T. Itayasu, Shinzo Hiroi et al. · Diabetes Obesity and Metabolism · 2011 · 84 citations

Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study

Yutaka Seino, Tetsuya Fujita, Shinzo Hiroi et al. · Current Medical Research and Opinion · 2011 · 77 citations

Metabolic Syndrome, Adverse Events, Diabetes Management +14

Impact of health insurance coverage for <i>Helicobacter pylori</i> gastritis on the trends in eradication therapy in Japan: retrospective observational study and simulation study based on real-world data

Shinzo Hiroi, Kentaro Sugano, Shiro Tanaka et al. · BMJ Open · 2017 · 68 citations · Full text